Major U.S. health system brings award-winning comprehensive clinical
decision support to the upper Midwest
CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth,
Inc. (Nasdaq: NH), a leading next-generation, evidence-based,
personalized healthcare company, today announced that Sanford Health,
one of the largest health systems in the nation, has entered into a
commercial license agreement for the use of its eviti®,
the evidence-based treatment intelligence and web-based oncology
decision support platform, which was recently named #1
Clinical Decision Support solution for 2016 by Black Book Market
Research.
Under terms of the agreement, Sanford Health's network of oncologists
will have access to NantHealth's eviti Connect decision support
solution, providing them with evidence-based regimens,
condition-specific clinical trial options and the potential for more
efficient preauthorization and expedited reimbursement. Further, the
eviti service holds the promise of delivering OMICS data for
bio-specific therapy. Sanford Health, based in the Dakotas, joins over
75 percent of U.S. oncology practices who have used the eviti platform
to make better clinical decisions earlier in the treatment process.
eviti Connect will be deployed to streamline system-wide processes for
the prescribing of high-quality, cost-effective treatments while
improving the flow of information between Sanford Health and its
providers. All of the participants in the cancer care process benefit
from eviti’s collaborative, real-time approach to improving care and
lowering risks and costs.
In order for oncologists to serve as many cancer patients as possible,
select treatment plans with the best possible outcome, and with the most
responsible economic profile, the technology solution must have the
rapid-learning and data compilation capabilities of true
super-computing. eviti’s clinical decision support is easy to use while
computing massive amounts of complex data to quickly present appropriate
treatment options, including the latest peer-reviewed and proprietary
immunotherapy clinical trials. eviti applications go beyond the
capabilities of most traditional electronic medical records systems to
present treatment options personalized for each patient’s need.
"Sanford Health Plan is committed to offering oncologists in our
networks the support they need to provide the best, most advanced
patient care possible," said Kirk Zimmer, Executive Vice President,
Sanford Health Plan. "eviti gives physicians real-time access to the
widest range of evidenced-based treatment options available, and
further, to ensure that the care they provide meets the clinical
requirements for reimbursement. This comprehensive approach stands to
improve clinical outcomes, while reducing claims denials and potentially
costs."
The eviti platform provides physicians real-time access to its
comprehensive, unbiased Evidence-Based Medical Library, which
encompasses over 2,700 of the most appropriate, evidence-based treatment
regimens covering all cancers and cancer subtypes and all modalities.
Each regimen incorporates level of evidence, expected clinical outcomes,
treatment costs, toxicities and any supporting literature. This
evidence-based medical library is meticulously compiled from
peer-reviewed literature, oncology associations, and government
agencies. The library is maintained by a full-time team of oncologists
and oncology nurses, clinical informatics professionals, and an advisory
board of nationally recognized oncology experts.
"We are pleased to enter into this partnership with Sanford Health and
look forward to working with the organization to enable their
oncologists to more quickly see and evaluate the spectrum of appropriate
treatment options in order to make even better, and more informed
treatment decisions," said Patrick Soon-Shiong, M.D., CEO of NantHealth.
"Today, independent studies show that nearly 32 percent of oncology
treatment plans deviate from evidence-based standards without medical
justification. While this is understandable given the rapidly growing
number of treatment options available to patients and their caregivers,
we must do better. Our goal is to provide a single, reliable source of
the most current information available to physicians, enabling them to
provide the right care at the right time—and to immediately know whether
that care will be covered."
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients, as well as our contribution to
the Cancer 2020 initiative. Forward-looking statements are subject to
numerous risks and uncertainties that could cause actual results to
differ materially from currently anticipated results. Factors that may
cause future results to differ materially from management’s current
expectations include, among other things, that GPS Cancer may not
perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the Securities and
Exchange Commission. These forward-looking statements speak only as of
the date hereof. We disclaim any obligation to update these
forward-looking statements except as may be required by law.
About eviti®, the nation's foremost evidence-based treatment
intelligence for decision support platform
eviti® is a SaaS-based, point-of-care clinical decision support platform
that allows oncologists to quickly see and assess treatment regimens,
outcomes, cost, and level of evidence in order to confidently select a
clinically-appropriate treatment. eviti consists of three applications –
eviti Advisor, eviti Advisor Enterprise, and eviti Connect® – that
together support advanced cancer care by aligning the priorities of
physicians, payors, and patients at the moment of clinical prescribing.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth‘s unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, CLINICS, which includes its
unique software, middleware and hardware systems infrastructure that
collects, indexes, analyzes and interprets billions of molecular,
clinical, operational and financial data points derived from novel and
traditional sources, continuously improves decision-making and further
optimizes our clinical pathways and decision algorithms over time. For
more information please visit www.nanthealth.com and
follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
About Sanford Health
Sanford Health is an integrated health system headquartered in the
Dakotas. It is one of the largest health systems in the nation with 43
hospitals and nearly 250 clinics in nine states and three countries.
Sanford Health’s 27,000 employees, including 1,400 physicians, make it
the largest employer in the Dakotas. Part of Sanford Health’s integrated
system, Sanford Health Plan is a non-profit health insurance company
spanning multiple levels of care for individuals, families, groups and
businesses. Sanford Health Plan’s commercial HMO has received
Commendable Accreditation from the National Committee for Quality
Assurance (NCQA).
View source version on businesswire.com: http://www.businesswire.com/news/home/20160803005578/en/
NantWorks
Jen Hodson, 562-397-3639
jhodson@nantworks.com
or
Sanford
Health
Tim Gerszewski, 605-366-2432
timothy.gerszewski@sanfordhealth.org
@SanfordTimG
Source: NantHealth, Inc.
